1.
World Health Organization (WHO). International Classification of Diseases, 10th Revision
(ICD-10). Geneva, Switzerland, WHO. 1992.
2.
Tanaka T. Colorectal carcinogenesis: Review of human and experimental animal studies.
Journal of carcinogenesis. 2009;8:5.
3.
Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey
BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer
deaths. The New England journal of medicine. 2012;366(8):687-96.
4.
Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and
overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
Clinical gastroenterology and hepatology : the official clinical practice journal
of the American Gastroenterological Association. 2015;13(4):717-23.
5.
Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O'Connor E, et al. Screening for
Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive
Services Task Force. Jama. 2016;315(23):2576-94.
6.
Garcia M. Addressing overuse and overdiagnosis in colorectal cancer screening for
average-risk individuals. Colorectal Cancer. 2015;4(1):27-35.
8.
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A. Primary colon cancer:
ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology.
2010;21 Suppl 5:v70-7.
12.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FAR,
et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation
Statement. Jama. 2016;315(23):2564-75.
13.
Jeong KE, Cairns JA. Review of economic evidence in the prevention and early detection
of colorectal cancer. Health Economics Review. 2013;3:20-.
14.
Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, et al. Estimation
of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling
Study for the US Preventive Services Task Force. Jama. 2016;315(23):2595-609.
16.
Jonas M. Volkswirtschaftlicher Nutzen eines Österreichischen Darmkrebsvorsorgeprogrammes//Economic
effects of the Austrian Colorectal Cancer Screening. Journal für Gastroenterologische
und Hepatologische Erkrankungen. 2017;15(1):14-8.
17.
Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer
screening. Epidemiologic reviews. 2011;33:88-100.
18.
Patel SS, Kilgore ML. Cost Effectiveness of Colorectal Cancer Screening Strategies.
Cancer control : journal of the Moffitt Cancer Center. 2015;22(2):248-58.
19.
Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal
cancer screening: a systematic review for the U.S. Preventive Services Task Force.
Annals of internal medicine. 2002;137(2):96-104.
22.
Siebert U. When should decision-analytic modeling be used in the economic evaluation
of health care? The European Journal of Health Economics. 2003;4(3):143-50.
23.
Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition
modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.
Value in health : the journal of the International Society for Pharmacoeconomics and
Outcomes Research. 2012;15(6):812-20.
24.
Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices--overview:
a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. Value in
health : the journal of the International Society for Pharmacoeconomics and Outcomes
Research. 2012;15(6):796-803.
25.
Drummond MF, Schwartz JS, Jonsson B, Luce BR, Neumann PJ, Siebert U, et al. Key principles
for the improved conduct of health technology assessments for resource allocation
decisions. International journal of technology assessment in health care. 2008;24(3):244-58;
discussion 362-8.
27.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated
Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ (Clinical research
ed). 2013;346:f1049.
28.
Hassan C, Quintero E, Dumonceau JM, Regula J, Brandao C, Chaussade S, et al. Post-polypectomy
colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Endoscopy. 2013;45(10):842-51.
29.
Statistics Austria. Personal communication. 2017.
31.
Brenner H, Jansen L, Ulrich A, Chang-Claude J, Hoffmeister M. Survival of patients
with symptom- and screening-detected colorectal cancer. Oncotarget. 2016;7(28):44695-704.
32.
Launois R, Le Moine JG, Uzzan B, Fiestas Navarrete LI, Benamouzig R. Systematic review
and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based
fecal occult blood tests for colorectal cancer screening. European journal of gastroenterology
& hepatology. 2014;26(9):978-89.
33.
Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer
screening. The New England journal of medicine. 2014;371(2):187-8.
34.
Hirai HW, Tsoi KK, Chan JY, Wong SH, Ching JY, Wong MC, et al. Systematic review with
meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates
in the proximal colon in colonoscopy-verified diagnostic studies. Alimentary pharmacology
& therapeutics. 2016;43(7):755-64.
35.
Austrian Colonoscopy Registry. Personal communication. 2017.
36.
Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz
KM. Evaluating test strategies for colorectal cancer screening: a decision analysis
for the U.S. Preventive Services Task Force. Annals of internal medicine. 2008.
37.
Bundo M, Jahn B, Arvandi M, Sroczynski G, Siebert U, editors. Adenoma Miss Rate of
Conventional Colonoscopy: a Systematic Review and Meta-Analysis [forthcoming poster
presentation] EbM-Kongress 2018; 2018; Graz, Austria.
38.
Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and
colonoscopy for detection--systematic review and meta-analysis. Radiology. 2011;259(2):393-405.
39.
Main Association of Austrian Security Institutions (Hauptverband der österreichischen
Sozialversicherungsträger-HBV). Original data on medical costs. Personal communication.
2017.
41.
McDowell M, Rebitschek FG, Gigerenzer G, Wegwarth O. A Simple Tool for Communicating
the Benefits and Harms of Health Interventions: A Guide for Creating a Fact Box. MDM
Policy Pract. 2016;1(1):2381468316665365.
42.
Hunink MM, Weinstein MC, Wittenberg E, Drummond MF, Pliskin JS, Wong JB, et al. Decision
making in health and medicine: integrating evidence and values: Cambridge University
Press; 2014.
43.
Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health
and medicine: Oxford University Press; 2016.
44.
Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and
guaiac faecal occult blood tests: a systematic review and meta-analysis. Preventive
medicine. 2012;55(2):87-92.
45.
Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez-Cendales B, Ferroni E, et al.
Meta-analysis: adherence to colorectal cancer screening and the detection rate for
advanced neoplasia, according to the type of screening test. Alimentary pharmacology
& therapeutics. 2012;36(10):929-40.
46.
Ran T, Cheng CY, Misselwitz B, Brenner H, Ubels J, Schlander M. Cost-Effectiveness
of Colorectal Cancer Screening Strategies-A Systematic Review. Clinical gastroenterology
and hepatology : the official clinical practice journal of the American Gastroenterological
Association. 2019.
47.
Zauber AG. Cost-Effectiveness of Colonoscopy. Gastrointestinal endoscopy clinics of
North America. 2010;20(4):751-70.
49.
Brenner G, Faure H, Heuer S, Reinholz J. [Detection of colorectal findings for cancer
prevention by immunochemical stool test with different sensitivity levels]. Zeitschrift
fur Gastroenterologie. 2012;50(10):1083-8.
50.
Bretthauer M, Kaminski MF, Loberg M, Zauber AG, Regula J, Kuipers EJ, et al. Population-Based
Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA internal
medicine. 2016;176(7):894-902.
51.
Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I, et al. Impact of comorbid
conditions on participation in an organised colorectal cancer screening programme:
a cross-sectional study. BMC cancer. 2017;17(1):524.